I’ll Take A Corporate Tax Holiday (Any Way You Slice It)

HedgeFundLIVE.com — Congress, lobbyists, and the White House continue to go back and forth on the issue of a corporate tax holiday.  In simple terms, this one-time event would allow U.S. companies to bring offshore cash holdings into the United States at a reduced tax rate, to repatriate it.  Usually, if a U.S. company profits from the sale of goods in a foreign country, and then deposits that profit in a bank within that country, the company will be taxed at the foreign country’s corporate tax rate, not the U.S.’s.  Should that country transfer those monies to its U.S. operations, however, the company will have to pay the I.R.S. the difference between the foreign country’s corporate tax rate and the U.S.’s corporate tax rate.

Let’s take the pharmaceutical industry for example.  Pfizer, for many years, has manufactured much of their Viagra supply in Ireland.  Pfizer then sells their little blue pills and holds their profits in Irish accounts resulting in a measly 12.5% tax rate on those profits.  If Pfizer brings those same profits into the U.S. they would have to pay the I.R.S. somewhere in the neighbourhood of an additional 22.5% in taxes, since the U.S. corporate tax rate is around 35% in most cases.  So you can see that Pfizer has just about no incentive to change those Euros into Dollars.

These days, Washington lobbyists and many Republicans (some Democrats too) are urging President Obama to implement a one-time tax holiday that will lower the chunk that the I.R.S. takes from repatriated funds to about 5%.  This, proponents say, would act as a veritable stimulus as large multinational corporations would bring billions and billions of dollars to their U.S. operations.  

Click Here for full article. 


NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.